ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MARLENE SARKIS MD

79 SWIFTWATER RD COTTAGE HOSPITAL INTERNAL MEDICINE, SUITE 2

Woodsville | New Hampshire | 03785

(603) 747-2900

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,824Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 251

$341K Total Retail Price of All Prescriptions

Rank: 48 out of 251

226 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 226 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 226 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 4,891 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
SIMVASTATIN 302 264 1 1
OMEPRAZOLE 235 168 2 5
PRAVASTATIN SODIUM 207 175 3 14
METFORMIN HCL 199 135 4 10
AMLODIPINE BESYLATE 196 188 5 4
LISINOPRIL 184 144 6 2
LOSARTAN POTASSIUM 159 127 7 17
ATENOLOL 157 122 8 12
GABAPENTIN 152 89 9 16
FUROSEMIDE 142 86 10 6
LEVOTHYROXINE SODIUM 134 102 11 3
HYDROCHLOROTHIAZIDE 122 119 12 9
CITALOPRAM HBR 118 79 13 15
TRAZODONE HCL 111 38 14 26
METOPROLOL TARTRATE 111 103 14 7
ZOLPIDEM TARTRATE 108 62 16 19
RANITIDINE HCL 101 79 17 35
ENALAPRIL MALEATE 100 83 18 61
ALENDRONATE SODIUM 99 88 19 39
FAMOTIDINE 97 62 20 75
DIOVAN 95 95 21 23
AMITRIPTYLINE HCL 86 53 R 22 70
ADVAIR DISKUS 76 50 23 25
POTASSIUM CHLORIDE 75 44 24 33
GLYBURIDE 74 59 R 25 64
PREDNISONE 71 30 26 27
NEXIUM 70 30 27 28
ATORVASTATIN CALCIUM 67 51 28 8
CELEBREX 66 55 29 81
BUPROPION HCL SR 64 27 30 128
CLOPIDOGREL 62 62 31 60
FLUTICASONE PROPIONATE 60 25 32 38
TAMSULOSIN HCL 56 50 33 32
DILTIAZEM 24HR ER 54 37 34 106
FLUOXETINE HCL 50 25 35 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.